5 Results for "

histone acetylation and methylation

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "histone acetylation and methylation" in MCE Product Catalog:

Cat. No.: HY-W014004
CAS No.: 174664-65-4
Synonyms: CBHA
Target:  

HDAC Apoptosis

Research Areas:  

Others Cancer

m-Carboxycinnamic acid bishydroxamide (CBHA) is a histone deacetylase inhibitor. m-Carboxycinnamic acid bishydroxamide modulates histone acetylation sites, alters DNA methylation and epigenetic status, increases global histone acetylation, alleviates transcription repression, and facilitates chromatin remodelling. m-Carboxycinnamic acid bishydroxamide can be used for the research of cloned embryo development and epigenetic regulation .
loading...
    loading...
Cat. No.: HY-P2555
CAS No.: 2130981-29-0
Target:  

Inhibitory Antibodies

Research Areas:  

Others

Histone H3 (23-34) is the histone H3 amino acid residues 23 to 34. Histone H3 (23-34) contains lysine residues at positions 23 and 27 that are subject to methylation and acetylation .
loading...
    loading...
Cat. No.: HY-163592
CAS No.: 3034746-11-4
Research Areas:  

Cancer

PRMT5-IN-43 (compound 4A) is a PRMT5 inhibitor. PRMT5-IN-43 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-163593
CAS No.: 3034746-35-2
Research Areas:  

Cancer

PRMT5-IN-44 (compound 12) is a PRMT5 inhibitor. PRMT5-IN-44 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-L024
931 compounds

A histone modification, a covalent post-translational modification (PTM) to histone proteins, includes methylation, phosphorylation, acetylation, ubiquitylation, and sumoylation, etc. In general, histone modifications are catalyzed by specific enzymes that act predominantly at the histone N-terminal tails involving amino acids such as lysine or arginine, as well as serine, threonine, tyrosine, etc. The PTMs made to histones can impact gene expression by altering chromatin structure or recruiting histone modifiers. Histone modifications act in diverse biological processes such as transcriptional activation/inactivation, chromosome packaging, and DNA damage/repair. Deregulation of histone modification contributes to many diseases, including cancer and autoimmune diseases.

MCE owns a unique collection of 931 bioactive compounds targeting Epigenetic Reader Domain, HDAC, Histone Acetyltransferase, Histone Demethylase, Histone Methyltransferase, Sirtuin, etc. Histone Modification Research Compound Library is a useful tool for histone modification research and drug screening.